Crupi, F. (2026) “B07 | Molecular risk profiling in myeloproliferative neoplasms blast phase treated with venetoclax and decitabine: a three-gene score for survival prediction: <a href="https://haematologica.org/search/search?query=F.+Crupi">F. Crupi</a><sup>1|2|3</sup>, <a href="https://haematologica.org/search/search?query=P.+Guglielmelli">P. Guglielmelli</a><sup>1|2|3</sup>, <a href="https://haematologica.org/search/search?query=F.+Mannelli">F. Mannelli</a><sup>1|2|3</sup>, <a href="https://haematologica.org/search/search?query=J.+Caroprese">J. Caroprese</a><sup>1|2|3</sup>, <a href="https://haematologica.org/search/search?query=M.+Lomi">M. Lomi</a><sup>1|3</sup>, <a href="https://haematologica.org/search/search?query=G.+G.+Loscocco">G. G. Loscocco</a><sup>2|3</sup>, <a href="https://haematologica.org/search/search?query=N.+Bartalucci">N. Bartalucci</a><sup>1|3</sup>, <a href="https://haematologica.org/search/search?query=S.+Soddu">S. Soddu</a><sup>4</sup>, <a href="https://haematologica.org/search/search?query=C.+Maccari">C. Maccari</a><sup>1|3</sup>, <a href="https://haematologica.org/search/search?query=A.+Enderti">A. Enderti</a><sup>1|3</sup>, <a href="https://haematologica.org/search/search?query=L.+Signori">L. Signori</a><sup>1|3</sup>, <a href="https://haematologica.org/search/search?query=A.+Piciocchi">A. Piciocchi</a><sup>4</sup>, <a href="https://haematologica.org/search/search?query=P.+Fazi">P. Fazi</a><sup>4</sup>, <a href="https://haematologica.org/search/search?query=A.+M.+Vannucchi">A. M. Vannucchi</a><sup>1|2|3</sup> | <i><sup>1</sup>Dipartimento di Medicina Sperimentale e Clinica, Università di Firenze; <sup>2</sup>SOD Ematologia, AOU Careggi; <sup>3</sup>Centro Ricerca e Innovazione Malattie Mieloproliferative CRIMM, AOU Careggi; <sup>4</sup>Fondazione GIMEMA</i&gt;”, Haematologica. Pavia, Italy, 111(s1). doi: 10.3324/haematol.2026.s1.15.